Quantum Biopharma-B Sub VotQNTM
13F holders, Q1 2026 (March 31)25holders +1
7new positions
6sold out
1famous investor
$4.83avg. 13F price*
At the end of Q1 2026, 25 institutions reported holding Quantum Biopharma-B Sub Vot (QNTM) in their 13F filings, up 1 from Q4 2025. 7 opened new positions and 6 sold out. The largest holders were AdvisorShares Investments LLC ($524K), Platform Technology Partners ($199K) and Jane Street Group, LLC ($152K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Quantum Biopharma-B Sub Vot
- CUSIP
- 74764Y205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $251K |
| Exits | 6 | $104K |
All 13F filers, Q4 2025 → Q1 2026: 140,213 shares bought and 14,294 shares sold, net +125,919 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 25 holders
| AdvisorShares Investments LLC | 0.10% | Add +118.8% | 108,591 | $524K |
| Platform Technology Partners | 0.04% | New | 41,116 | $199K |
| Jane Street Group, LLC | 0.00% | Add +189.2% | 31,501 | $152K |
| Citadel Advisors | 0.00% | No change | 15,863 | $77K |
| Marex Group Ltd | 0.00% | Add +0.2% | 13,468 | $65K |
| Virtu Financial LLC | 0.00% | Add +18.0% | 12,282 | $59K |
| Mariner, LLC | 0.00% | New | 10,059 | $49K |
| UBS Group AG | 0.00% | Add +323.2% | 7,237 | $35K |
| Osaic Holdings, Inc. | 0.00% | Add +21.0% | 6,375 | $31K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 4,381 | $21K |
| Atlantic Union Bankshares Corp | 0.00% | No change | 1,000 | $5K |
| Farther Finance Advisors, LLC | 0.00% | No change | 1,000 | $4K |
| Jones Financial Companies LLLP | 0.00% | New | 700 | $3K |
| Cetera Trust Company, N.A | 0.00% | No change | 250 | $1K |
| Wells Fargo & Company | 0.00% | New | 100 | $477 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 93 | $369 |
| SBI Securities Co., Ltd. | 0.00% | Add +36.4% | 75 | $362 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 71 | $343 |
| Group One Trading LLC | 0.00% | No change | 34 | $164 |
| Rockefeller Capital Management L.P. | 0.00% | No change | 30 | $145 |
| National Bank of Canada | 0.00% | New | 20 | $93 |
| TD Waterhouse Canada Inc. | 0.00% | New | 20 | $88 |
| Activest Wealth Management | 0.00% | No change | 15 | $72 |
| Purpose Unlimited Inc. | 0.00% | No change | 1 | $4 |
| Royal Bank of Canada | 0.00% | Reduce -65.5% | 19 | $0 |
"% of holder's portfolio" is QNTM's weight in each manager's 13F, not the share of Quantum Biopharma-B Sub Vot the manager owns.